Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients

被引：27
|
作者：
Nash, Tammon [1 ]
Hoffmann, Sandra [2 ]
Butch, Suzanne [2 ]
Davenport, Robertson [2 ]
Cooling, Laura [2 ]
机构：
[1] Michigan Blood, Grand Rapids, MI USA
[2] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
来源：
TRANSFUSION | 2012年 / 52卷 / 10期
关键词：
BLOOD-PRODUCTS; TRANSFUSION; TRANSMISSION; INFECTION;
D O I：
10.1111/j.1537-2995.2012.03739.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2270 / 2272
页数：3
相关论文
共 50 条
  • [1] Prestorage leukocyte reduced, CMV untested blood components are safe for use in CMV-negative allogeneic bone marrow transplant recipients
    Hoffmann, S.
    Herrst, M.
    Butch, S.
    Cooling, L. W.
    TRANSFUSION, 2007, 47 (03) : 212A - 213A
  • [2] PREVENTION OF PRIMARY CYTOMEGALOVIRUS (CMV) INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANT PATIENTS (BMT PTS) BY CMV-NEGATIVE BLOOD PRODUCTS AND INTRAVENOUS IMMUNOGLOBULIN
    ASH, RC
    BRATANOW, NC
    RAYBOULD, T
    FERRETTI, G
    OLDHAM, K
    GOTTSCHALL, J
    MENITOVE, J
    ASTER, R
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 542 - 542
  • [3] Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia
    Luis Pinana, Jose
    Gimenez, Estela
    Dolores Gomez, Maria
    Perez, Ariadna
    Maria Gonzalez, Eva
    Vinuesa, Victor
    Carlos Hernandez-Boluda, Juan
    Montoro, Juan
    Salavert, Miguel
    Tormo, Mar
    Amat, Paula
    Moles, Paula
    Carretero, Carlos
    Balaguer-Rosello, Aitana
    Sanz, Jaime
    Sanz, Guillermo
    Solano, Carlos
    Navarro, David
    JOURNAL OF INFECTION, 2019, 78 (05) : 393 - 401
  • [4] Effect of Cytomegalovirus (CMV) Serostatus on the Incidence and Virological Features of Active CMV Infection in Allogeneic Stem Cell Transplant Recipients
    Solano, Carlos
    Tormo, Nuria
    de la Camara, Rafael
    Bartolo Nieto, Jose
    Lopez, Javier
    Benet, Isabel
    Munoz-Cobo, Beatriz
    Costa, Elisa
    Jose Remigia, Maria
    Garcia-Noblejas, Ana
    Bravo, Dayana
    Navarro, David
    CLINICAL INFECTIOUS DISEASES, 2011, 53 (03) : 313 - 315
  • [5] CMV-NEGATIVE BLOOD PRODUCTS FOR PREVENTION OF CYTOMEGALOVIRAL PNEUMONIA (CMV-IP) IN SERONEGATIVE (CMV-NEG) TRANSPLANT RECIPIENTS - A STUDY IN 50 PATIENTS
    HARRIS, R
    NEUDORF, S
    MCGILL, M
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 242 - 242
  • [6] An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients
    Talaya, Alberto
    Gimenez, Estela
    Pascual, Maria Jesus
    Gago, Beatriz
    Pinana, Jose Luis
    Hernandez-Boluda, Juan Carlos
    Vazquez, Lourdes
    Garcia, Magdalena
    Serrano, David
    Hernandez, Marta
    Albert, Eliseo
    Solano, Carlos
    Navarro, David
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2020, 209 (01) : 15 - 21
  • [7] Effect of Cytomegalovirus (CMV) Serostatus on the Incidence and Virological Features of Active CMV Infection in Allogeneic Stem Cell Transplant Recipients Reply
    Pietersma, Floor L.
    van Baarle, Debbie
    CLINICAL INFECTIOUS DISEASES, 2011, 53 (03) : 315 - 316
  • [8] An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients
    Alberto Talaya
    Estela Giménez
    María Jesús Pascual
    Beatriz Gago
    José Luis Piñana
    Juan Carlos Hernández-Boluda
    Lourdes Vázquez
    Magdalena García
    David Serrano
    Marta Hernández
    Eliseo Albert
    Carlos Solano
    David Navarro
    Medical Microbiology and Immunology, 2020, 209 : 15 - 21
  • [9] THE EFFECT OF DONOR CMV SEROSTATUS ON CMV INFECTION AND OUTCOME IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS
    Green, J. S.
    Mulroney, C. M.
    Curtin, P. T.
    Taplitz, R. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S234 - S235
  • [10] Incidence of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell recipients at low risk of CMV infection
    Mori, T
    Okamoto, S
    Watanabe, R
    Yamazaki, R
    Tsukada, Y
    Nagayama, H
    Ishida, A
    Ikeda, Y
    BONE MARROW TRANSPLANTATION, 2002, 29 (12) : 1005 - 1006
12345